ICL Group Ltd.’s SEC filings document its reporting as a foreign private issuer with shares listed on the NYSE and TASE. Form 20-F and Form 6-K disclosures cover the company’s specialty minerals operations, segment performance, investor presentations, audited financial statements and risk factors related to commodity markets, exchange rates, mineral extraction permits and regional conditions in Israel.
Current reports also record dividend distributions, credit-rating updates, executive-management governance matters, registration-statement and Israeli shelf-prospectus incorporation references, and material agreements affecting the Dead Sea concession assets. These filings describe capital-return mechanics, tax withholding on distributions, board actions, and the company’s potash, phosphate, bromine, growing solutions and industrial product activities.
ICL Group Ltd. is the issuer for which Phoenix Financial Ltd. reported 64,808,308.76 ordinary shares as beneficially owned through its direct or indirect, majority- or wholly owned subsidiaries. The cover reports shared voting and dispositive power over this amount and a 5.02% position, based on 1,290,718,361 ICL ordinary shares outstanding as of October 28, 2026, using Bloomberg LP data. The reported holdings included 45,712,384 shares beneficially owned by Partnership for Israeli shares and 17,389,319.76 shares beneficially owned by The Phoenix Investments House - trust funds.
Phoenix states that the subsidiaries operate independently and make their own voting and investment decisions. It disclaims beneficial ownership beyond actual pecuniary interests and says the statement is not an admission that a group exists or that the reporting parties beneficially own any covered shares.
ICL Group Ltd. (ICL) reports the results of its 2026 Annual General Meeting of Shareholders held on September 17, 2026. Shareholders approved, by the applicable required majority, all proposals described in the company’s proxy statement, including the election of the full slate of director nominees and the reappointment of the external auditor.
Director nominees received very strong support, generally above 99% of votes cast, such as Michal SilverbergLior ReitblattSomekh Chaikin (KPMG)
ICL Group Ltd. (ICL) provides supplemental details on a previously announced dividend distribution of about $75 million from earnings. The dividend equals $0.05811 per share for shareholders receiving U.S. dollars and ILS 0.1750273 per share for those receiving Israeli shekels, based on the Bank of Israel’s representative exchange rate on the announcement date.
The dividend will be paid to registered shareholders entitled to receive at least US$2, with a record date of September 2, 2026 and a payment date of September 16, 2026. Israeli withholding tax will apply at differentiated rates to approximately 65% and 35% portions of the dividend, depending on the recipient’s residency and status, with possible treaty reductions and a noted refund procedure for certain NYSE-held shares.
ICL Group Ltd. (ICL) reports that Phoenix Financial Ltd. and its subsidiaries beneficially own 64,298,945.76 Ordinary Shares of ICL, representing 4.98% of the class, based on 1,290,718,361 Ordinary Shares outstanding as of August 16, 2026. As of August 13, 2026, these holdings are spread across several Phoenix-related entities, including 18,412,088.76 shares held by The Phoenix Investments House trust funds, 44,883,318 shares by Partnership for Israeli shares, 148,166 shares by Partnership for investing in shares indexes, 284,619 shares by Phoenix pension and provident funds, and 570,754 shares by linked insurance policies of Phoenix. Phoenix states that each subsidiary has independent management and investment decisions and disclaims group status and beneficial ownership beyond its actual pecuniary interest.
ICL Group Ltd. reported a grant of stock options to its EVP, Global CIO, Alegra Kilstein. The award covers 731,707 stock options to buy Ordinary Shares at an exercise price of $5.05 (NIS 15.31) per share, vesting in three equal annual installments from August 4, 2026 and expiring on August 4, 2031. The options are held by a trustee in her name.
ICL Group Ltd. granted its CFO, Asaf Alperovitz, stock options to acquire 1,829,268 Ordinary Shares at an exercise price of NIS 15.31 per share, shown as $5.0500 using a $1.00 to NIS 3.0300 rate as of 8/4/2026. The options vest in three equal annual installments from the 8/4/2026 grant date, expire on 2031-08-04, and are held by a Trustee in his name.
ICL Group Ltd. approved adjustments to its organizational structure on August 4, 2026, effective January 1, 2027, to align management with its updated November 2025 strategy. The company will adopt an end-market-oriented operating model focused on Agriculture, Food and Industrial markets, with greater emphasis on Food activities.
Under the revised structure, ICL will report four operating segments: Growing Solutions (specialty crop nutrition), Nutrition Solutions (food, beverage, health and nutrition), Industrial Products (performance and safety solutions) and Essential Minerals (potash and phosphate fertilizers from upstream mineral sites). For investor context, ICL provided preliminary, unaudited historical segment data: Q2 2026 consolidated sales of 2,135 and operating income of 266, and full-year 2025 sales of 7,153 and operating income of 580, all recast under the new segment definitions and subject to change as accounting implications are finalized.
ICL Group Ltd. reported strong second-quarter 2026 performance, with total sales of $2.1 billion, up 17% from the prior year. Adjusted, non‑GAAP profitability improved, as adjusted net income reached $149 million, up 35%, and adjusted EBITDA was $448 million, up 28% versus second quarter 2025.
Adjusted diluted EPS, a non‑GAAP measure, rose 33% to $0.12. Operating cash flow was $290 million, with free cash flow of $94 million. Management highlighted price increases across fertilizer, food and industrial markets, while noting continued pressure from higher raw material costs and foreign-exchange headwinds. The CEO also reiterated strategic priorities around potash and phosphate, bromine market leadership, portfolio and cost optimization, and specialty crop nutrition and food solutions.
ICL Group Ltd. reports that its board of directors resolved on August 4, 2026 to declare a cash dividend of $0.05811 per share, totaling about $75 million. Some shareholders will be paid in New Israeli Shekels, with the NIS amount based on the Bank of Israel representative exchange rate on September 1, 2026. The dividend will be paid only to registered shareholders entitled to receive at least US $2.
The record date is September 2, 2026 and the payment date is September 16, 2026. For about 65% of the dividend, Israeli-resident individuals face 25% withholding and foreign residents 25% or a lower treaty rate. For about 35% of the dividend, Israeli-resident individuals face 20% withholding and foreign residents 20% or a lower treaty rate. Israeli-resident companies are not subject to withholding on either portion.
ICL Group Ltd. reported strong Q2 2026 results, with sales of $2.135 billion, up 17% from $1.832 billion a year earlier. Operating income rose to $266 million from $181 million, while adjusted operating income increased to $281 million from $201 million. Net income attributable to shareholders was $137 million versus $93 million, and adjusted net income was $149 million, up 35% from $110 million. Adjusted EBITDA grew to $448 million from $351 million, and diluted EPS was $0.11, with adjusted diluted EPS of $0.12, up 33% from $0.09. Operating cash flow reached $290 million and free cash flow was $94 million, up 34%.
Management highlighted contributions from all four segments and reiterated 2026 guidance for consolidated adjusted EBITDA of $1.5 billion to $1.7 billion, alongside expected potash sales volumes of 4.5–4.7 million tonnes. The company plans a major organizational realignment effective January 1, 2027, into Growing Solutions, Nutrition Solutions, Industrial Products and Essential Minerals, to align with its strategy. ICL also launched the enterprise-wide Elevate cost program, targeting more than $350 million of annualized savings by the end of 2028, with significant savings expected from early 2027.
Liquidity remained solid, with cash, cash equivalents, short-term investments and deposits of $662 million and about $1.6 billion of unused credit facilities as of June 30, 2026. Net financial liabilities were $2,635 million, up $375 million since year-end 2025, reflecting, among other items, a new $800 million Series H Debenture issuance maturing in 2036 at a 6.036% coupon. Both Fitch Ratings and S&P Global Ratings reaffirmed ICL’s BBB- ratings with stable outlooks. The company noted that, despite regional security tensions, the security situation in Israel had not, as of the reporting date, had a material impact on its business results, though future effects remain uncertain.